Modernization and AI strategy for regulated healthcare and life sciences.

AI governance in healthcare splits into two regulatory regimes that demand different evidentiary disciplines. Clinical AI that meets the FDA's software-as-a-medical-device definition requires premarket submission evidence under the SaMD framework and the FDA's AI/ML action plan, including a predetermined change control plan if the model will continue learning post-market. Operational and administrative AI sits outside FDA jurisdiction but inside HIPAA, ONC information-blocking, and emerging state-level statutes such as California AB 3030 and Colorado's AI Act. The work begins with a use-case taxonomy that places each model on the right regulatory track, followed by validation design appropriate to the consequence tier. A senior consultant produces bias-and-fairness testing protocols stratified by the demographic categories the institution actually serves, drift-monitoring thresholds that reflect clinical-meaningfulness rather than statistical convenience, predetermined change control plan drafts where SaMD applies, and the documentation package the institution's IRB, privacy office, and chief medical officer expect to see. Successful outcomes look like a clinical AI tool that ships with monitoring instrumented from day one, an operational AI tool that withstands an OCR or state-AG inquiry, and a governance committee that can approve or pause new use cases on a known cadence. An engagement typically runs eight to twelve weeks, embedded with the chief medical informatics officer, the privacy office, regulatory affairs for SaMD scope, and the data-science team owning the model.

A HIPAA-aligned cloud architecture is a landing zone where every data flow that touches protected health information is segmented, logged, and encrypted in a way the Office for Civil Rights would expect to see during an investigation. The work begins with a PHI data-flow inventory, a business-associate-agreement boundary map across the institution's vendors, and a control mapping to the HIPAA Security Rule, the HHS recognized security practices framework, and the 405(d) Health Industry Cybersecurity Practices guidance. A senior consultant produces account or subscription segmentation aligned to PHI versus non-PHI workloads, network isolation patterns that prevent inadvertent PHI transit, key-management posture under FIPS 140-3 where applicable, and an audit-log architecture that captures access, configuration change, and data-egress events with retention windows the OCR investigator expects. Deliverables include landing-zone-as-code, the BAA-aware vendor catalog, an evidence package mapping HIPAA Security Rule citations to technical controls, and incident-response runbooks for the breach-notification scenarios the institution is most likely to face. Successful outcomes look like a routine OCR audit that closes without a corrective action plan, a posture that supports new clinical or research workloads without architecture redesign, and a security operations team that can answer breach-investigation questions in hours rather than weeks. An engagement typically runs eight to twelve weeks, embedded with cloud engineering, the privacy and security offices, and the compliance officer.

EHR modernization in 2026 is rarely a platform replacement; it is the optimization, integration, and governance work that determines whether an Epic or Cerner footprint produces clinical workflow improvement or a decade of frustration. The work begins with a clinician-experience baseline, an integration inventory of the third-party applications inside the HL7 FHIR perimeter, and a compliance assessment against the ONC information-blocking rule and the 21st Century Cures Act Application Programming Interface (API) requirements. A senior consultant produces FHIR API governance for third-party integrations, Substitutable Medical Applications, Reusable Technologies (SMART)-on-FHIR app review patterns, a clinical-content governance model for order sets and documentation templates, and a modernization roadmap that distinguishes optimization work from platform-replacement work. Deliverables include an integration architecture review, an information-blocking exposure assessment, a clinician-feedback program tied to release cadence, and an interoperability program that makes United States Core Data for Interoperability (USCDI) compliance an operational outcome rather than a project. Successful outcomes look like measurable clinician documentation-time reduction, an information-blocking posture that withstands a complaint review, and a platform that supports new value-based-care arrangements without bespoke integration work each time. An engagement typically runs ten to sixteen weeks, embedded with the chief medical informatics officer, the EHR application team, the integration platform team, and the compliance lead responsible for ONC obligations.

Pharma data platforms operate under GxP discipline, which means every system that produces data supporting a regulatory submission must demonstrate validation evidence under FDA 21 CFR Part 11, EU Annex 11, and the institution's own validation master plan. The work begins with a system inventory split between GxP and non-GxP scopes, a data-integrity assessment against ALCOA+ principles, and a clinical-trial or manufacturing data-flow map that traces source data to submission artifact. A senior consultant produces validation packages (IQ, OQ, PQ) for the data-platform layers, computer-system-validation documentation that aligns to GAMP 5 risk-based scoping, audit-trail architecture for the regulated data stores, and the data-contract discipline that lets clinical operations, manufacturing, and regulatory affairs share authoritative datasets without parallel reconciliation. Deliverables include a validated lakehouse or warehouse foundation, a Computer System Validation (CSV) evidence library, a data-quality monitoring framework keyed to the data-integrity controls inspectors actually examine, and a change-control process that survives an FDA 483 review. Successful outcomes look like an FDA inspection that closes without a data-integrity finding, a clinical-trial data lock that completes inside the planned window, and a manufacturing-data platform that supports both batch-release decisions and continued process verification. An engagement typically runs twelve to twenty weeks, embedded with quality assurance, regulatory affairs, the validation lead, and the data-platform engineering team.

Provider operational resilience is the discipline that determines whether a clinical-system outage becomes a documented incident with controlled patient-safety impact or a regional news story. The work begins with a clinical-system criticality tiering, a downtime-procedure inventory across inpatient, outpatient, ED, OR, and lab settings, and a recovery-objective assessment grounded in actual measured recovery rather than aspirational targets. A senior consultant produces tabletop and full-failover exercise designs for the highest-criticality systems, downtime-procedure refresh aligned to current clinical workflows, an after-action discipline that converts findings into closed risk items, and a board-level reporting pack on operational resilience aligned to the Joint Commission, Centers for Medicare & Medicaid Services (CMS) Conditions of Participation, and the HHS 405(d) framework. Deliverables include the criticality register, refreshed clinical downtime procedures, a tested incident-command structure that integrates IT incident response with clinical operations leadership, and a third-party risk register for the Software as a Service (SaaS) clinical applications now on the critical path. Successful outcomes look like a planned EHR-downtime exercise that completes inside the documented RTO, a real outage that activates the documented procedures rather than improvising, and a Joint Commission survey that closes cleanly on emergency operations and information management. An engagement typically runs eight to twelve weeks, embedded with the CMIO, the chief nursing informatics officer, IT operations leadership, and the emergency-management function.

Payer modernization centers on three platforms that determine whether a health plan operates efficiently or absorbs administrative cost the regulator and the market both penalize: the claims platform, the prior-authorization workflow, and the utilization-management decision layer. The work begins with a current-state assessment of the core admin platform (Facets, QNXT, HealthEdge, or a custom stack), a CMS interoperability and prior-authorization rule (CMS-0057-F) gap analysis, and a regulatory exposure assessment for AI-driven UM decisions under the emerging state-level statutes and the federal Mental Health Parity and Addiction Equity Act enforcement posture. A senior consultant produces a claims-platform replatforming roadmap with parallel-run reconciliation discipline, FHIR API design for the prior-authorization and patient-access requirements, governance over AI-driven UM models including the human-review gate that current state and federal expectations require, and a change-management plan for provider-network and member-facing impacts. Deliverables include the platform decision record, the CMS interoperability compliance evidence, a UM AI governance package, and an operational-readiness assessment for cutover. Successful outcomes look like an on-time prior-authorization API launch, a UM AI deployment that survives a regulator inquiry, and a claims migration that completes without a provider-payment disruption event. An engagement typically runs twelve to twenty weeks, embedded with the chief operating officer, the chief medical officer, regulatory affairs, and the platform program team.